BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 10234773)

  • 1. [Suppression of angiotensin-converting enzyme and myocardial ischemia].
    Eliseev OM
    Ter Arkh; 1999; 71(3):73-6. PubMed ID: 10234773
    [No Abstract]   [Full Text] [Related]  

  • 2. [Hypertension, heart failure, myocardial infarction, secondary prevention: the role of perindopril].
    Rapezzi C; Ciliberti P; Graziosi M; Riva L
    Ital Heart J; 2005 Nov; 6 Suppl 7():40S-47S. PubMed ID: 16485516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Rationale, characteristics and study design of PREAMI (Perindopril and Remodelling in the Elderly with Acute Myocardial Infraction)].
    Magrini G; Nicolosi GL; Chiariello M; Ferrari R; Remme P; Tavazzi L
    Ital Heart J; 2005 Nov; 6 Suppl 7():14S-23S. PubMed ID: 16485513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Ischemic heart disease with low risk of vascular complications -- a novel indication for angiotensin converting enzyme inhibitors (results of EUROPA trial)].
    Perepech NB
    Kardiologiia; 2004; 44(3):106-10. PubMed ID: 15489840
    [No Abstract]   [Full Text] [Related]  

  • 5. [The long way of angiotensin-converting enzyme inhibitors in the fight against cardiovascular diseases].
    Ferrari R; Ambrosio G; Chiariello M
    Ital Heart J; 2005 Nov; 6 Suppl 7():3S-4S. PubMed ID: 16485511
    [No Abstract]   [Full Text] [Related]  

  • 6. Perindopril and reference antihypertensives.
    Thurston H
    S Afr Med J; 1991 Oct; Suppl():10-4; discussion 15. PubMed ID: 1925813
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of angiotensin-converting enzyme inhibition with perindopril on left ventricular remodeling and clinical outcome: results of the randomized Perindopril and Remodeling in Elderly with Acute Myocardial Infarction (PREAMI) Study.
    Ferrari R;
    Arch Intern Med; 2006 Mar; 166(6):659-66. PubMed ID: 16567606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antihypertensive treatment and CHD in the elderly.
    Fink KS; Ellsworth A
    Am Fam Physician; 1999 Sep; 60(4):1102, 1104, 1107. PubMed ID: 10507742
    [No Abstract]   [Full Text] [Related]  

  • 9. [Angiotensin-converting enzyme inhibitors in patients with preserved left ventricular function: from EUROPA to PREAMI].
    Ferrari R; Papa K; Bernocchi P; Gimbatti OJ; Golcea SS; Bettini A; Ceconi C
    Ital Heart J; 2005 Nov; 6 Suppl 7():24S-32S. PubMed ID: 16485514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [ALLHAT].
    Ando K
    Nihon Rinsho; 2006 Aug; 64 Suppl 6():402-7. PubMed ID: 16981570
    [No Abstract]   [Full Text] [Related]  

  • 11. [The use of perindopril (prestarium) in arterial hypertension].
    Filatova NP
    Ter Arkh; 1995; 67(9):81-3. PubMed ID: 7495054
    [No Abstract]   [Full Text] [Related]  

  • 12. Blood pressure and stroke; the PROGRESS trial.
    He FJ; MacGregor GA
    J Renin Angiotensin Aldosterone Syst; 2001 Sep; 2(3):153-5. PubMed ID: 11881116
    [No Abstract]   [Full Text] [Related]  

  • 13. [PROGRESS].
    Hasegawa Y
    Nihon Rinsho; 2006 Aug; 64 Suppl 6():396-401. PubMed ID: 16983776
    [No Abstract]   [Full Text] [Related]  

  • 14. [Angiotensin-converting enzyme inhibitors and chronic ischemic heart disease--new indications?].
    Haghfelt T; Haghfelt A
    Ugeskr Laeger; 2004 Jan; 166(3):169-70. PubMed ID: 14870648
    [No Abstract]   [Full Text] [Related]  

  • 15. [Control of arterial hypertension in stroke prevention].
    Britov AN; Bystrova MM; Orlov AA
    Klin Med (Mosk); 2002; 80(6):53-7. PubMed ID: 12138805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Are all antihypertensive agents equal? Cardiovascular events in hypertensive patients randomized to treatment with doxazosin or chlorthalidone. The ALLHAT study].
    Schillaci G; Verdecchia P
    Ital Heart J Suppl; 2000 Sep; 1(9):1215-7. PubMed ID: 11140297
    [No Abstract]   [Full Text] [Related]  

  • 17. [Contribution of perindopril to the treatment of chronic congestive cardiac insufficiency. Multicenter pilot double blind study versus placebo].
    Bounhoure JP; Bottineau G; Lechat P; Garnham J; Lapeyre G
    Arch Mal Coeur Vaiss; 1989 May; 82 Spec No 1():73-8. PubMed ID: 2505716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Symposium on future prospects of angiotensin converting enzyme. Presentation of perindopril, a new and potent ACE inhibitor. Perindopril exerts an efficacious and rapid inhibition of ACE in plasma as well as in tissues].
    Med Clin (Barc); 1991 Apr; 96(16):suppl 2 p.. PubMed ID: 2051826
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparison between angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on the risk of myocardial infarction, stroke and death: a meta-analysis.
    Reboldi G; Angeli F; Cavallini C; Gentile G; Mancia G; Verdecchia P
    J Hypertens; 2008 Jul; 26(7):1282-9. PubMed ID: 18550998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparative study of the efficacy and tolerance of perindopril, a new converting enzyme inhibitor and of atenolol, a beta blocker].
    Rorive G; Creytens G; Ruhwiedel M; Van de Voorde K
    Rev Med Liege; 1990 Feb; 45(2):62-8. PubMed ID: 2180020
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.